Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Olefson Jonathan Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Disposed/sold 14,368 shares @ $43, valued at $617.8k
Disposed/sold 50,258 shares @ $0
02/24/2023 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Granted 2,609 shares @ $0
Granted 891 shares @ $0
Granted 602 shares @ $0
Paid exercise price by delivering 2,001 shares @ $38.25, valued at $76.5k
01/19/2023 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Paid exercise price by delivering 2,506 shares @ $34.76, valued at $87.1k
Granted 17,126 shares @ $0
Paid exercise price by delivering 936 shares @ $34.8, valued at $32.6k
12/19/2022 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Granted 23,128 shares @ $0
07/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2022 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Paid exercise price by delivering 2,370 shares @ $86.09, valued at $204k
Granted 6,121 shares @ $0
01/12/2022 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Paid exercise price by delivering 1,616 shares @ $93.69, valued at $151.4k
12/27/2021 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Sold 1,889 shares @ $100.95, valued at $190.7k
11/17/2021 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Gifted 500 shares @ $0
Gifted 237 shares @ $0
Paid exercise price by delivering 1,632 shares @ $98.37, valued at $160.5k
03/31/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/27/2021 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Sold 5,336 shares @ $75.68, valued at $403.8k
01/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/16/2020 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Paid exercise price by delivering 1,104 shares @ $63.25, valued at $69.8k
04/15/2020 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Granted 1,898 shares @ $0
01/17/2020 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Granted 6,692 shares @ $0
01/09/2020 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Paid exercise price by delivering 1,095 shares @ $59.96, valued at $65.7k
11/14/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2019 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Granted 10,068 shares @ $0
12/19/2018 4 Olefson Jonathan (General Counsel & Corp Secty) has filed a Form 4 on Syneos Health, Inc.
Txns: Bought 750 shares @ $41.273, valued at $31k
08/27/2018 4 Olefson Jonathan (SVP, Gen. Counsel, Secretary) has filed a Form 4 on Cotiviti Holdings, Inc.
Txns: Gifted 582 shares @ $0
Disposed/sold 427 shares @ $44.75, valued at $19.1k
Disposed/sold 4,316 shares @ $44.75, valued at $193.1k
Disposed/sold 13,200 options to buy @ $6.26, valued at $82.6k
Disposed/sold 58,200 options to buy @ $6.26, valued at $364.3k
Disposed/sold 5,490 options to buy @ $19, valued at $104.3k
Disposed/sold 20,937 options to buy @ $34.39, valued at $720k
Bought 28,368 options to buy @ $34.7, valued at $984.4k
Disposed/sold 458 restricted stock units @ $0
Disposed/sold 2,617 restricted stock units @ $0
Disposed/sold 11,347 restricted stock units @ $0
06/21/2018 4 Olefson Jonathan (SVP, Gen. Counsel, Secretary) has filed a Form 4 on Cotiviti Holdings, Inc.
Txns: Sold 20,000 shares @ $41.1, valued at $822k
Exercised 20,000 options to buy @ $6.26, valued at $125.2k
06/07/2018 4 Olefson Jonathan (SVP, Gen. Counsel, Secretary) has filed a Form 4 on Cotiviti Holdings, Inc.
Txns: Sold 10,000 shares @ $38, valued at $380k
Sold 5,400 shares @ $40, valued at $216k
Sold 4,600 shares @ $40.01, valued at $184k
Sold 5,000 shares @ $40, valued at $200k
Exercised 20,000 options to buy @ $6.26, valued at $125.2k
05/29/2018 4 Olefson Jonathan (SVP, Gen. Counsel, Secretary) has filed a Form 4 on Cotiviti Holdings, Inc.
Txns: Paid exercise price by delivering 68 shares @ $33.53, valued at $2.3k
Exercised 229 restricted stock units @ $0
02/05/2018 4 Olefson Jonathan (SVP, Gen. Counsel, Secretary) has filed a Form 4 on Cotiviti Holdings, Inc.
Txns: Paid exercise price by delivering 298 shares @ $34.7, valued at $10.3k
Granted 28,368 options to buy @ $34.7, valued at $984.4k
Granted 11,347 restricted stock units @ $0
Exercised 872 restricted stock units @ $0
12/06/2017 4 Olefson Jonathan (SVP, Gen. Counsel, Secretary) has filed a Form 4 on Cotiviti Holdings, Inc.
Txns: Sold 15,000 shares @ $32.37, valued at $485.6k
Exercised 15,000 options to buy @ $6.26, valued at $93.9k
07/17/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/24/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/09/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/03/2017 4 Olefson Jonathan (SVP, Gen. Counsel, Secretary) has filed a Form 4 on Cotiviti Holdings, Inc.
Txns: Granted 20,937 options to buy @ $34.39, valued at $720k
Granted 3,489 restricted stock units @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy